ArticleKidney diseases (Basel, Switzerland)

Urinary Myeloid Bodies as a Biomarker for Early Diagnosis and Monitoring of Enzyme Replacement Therapy in Fabry Disease.

Junlan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.